Viatris Inc (VTRS)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$1,805.7M
Cash & Equivalents
$388.3M
Quarterly Burn Rate
$18,831M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (12 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
SILDENAFIL CITRATE
REVATIO |
APPROVED | — |
|
PHENYTOIN
DILANTIN-30 |
APPROVED | — |
|
GABAPENTIN
NEURONTIN |
APPROVED | — |
|
SERTRALINE HYDROCHLORIDE
ZOLOFT |
APPROVED | — |
|
AMLODIPINE BESYLATE
NORVASC |
APPROVED | — |
|
ZIPRASIDONE MESYLATE
GEODON |
APPROVED | — |
|
PHENYTOIN SODIUM
DILANTIN |
APPROVED | — |
|
DOXAZOSIN MESYLATE
CARDURA XL |
APPROVED | — |
|
ZIPRASIDONE HYDROCHLORIDE
GEODON |
NDA | Actinic Keratosis, Acute Exacerbation of Psychosis, Acute Pain, Angina, Angina Pectoris, Anterior Ischemic Optic Neuropathy, Arthritis, Rheumatoid, Asthma, Atopic Dermatitis, Atrial Fibrillation, Atrophic Vaginitis, Carcinoma, Basal Cell, Cardiovascular Diseases, Cervical Pain, Chemotherapy-Induced Peripheral Neuropathy, Chronic Low Back Pain With a Neuropathic Component, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Contraception, COPD, Delusional Disorder, Depression, Diabetes Mellitus, Diabetes, Type 2, Diabetic Macular Edema, Diabetic Peripheral Neuropathy, Dovprela, Dry Eye, Dyslipidemia, Dyslipidemias, Epilepsies, Partial, Erectile Dysfunction, Familial Hypercholesterolemia, Female Sexual Arousal Disorder, Fibromyalgia, Genital Warts, Glaucoma, Glaucoma, Open-Angle, Healthy, Healthy Lactating Women, Healthy Volunteers, Hernia, Inguinal, Hypercholesterolemia, Hyperlipidemia, Hyperlipidemias, Hypertension, Impotence, Ischemic Optic Neuropathy, Low Back Pain, Male Uro |
|
TOBRAMYCIN
TOBI |
NDA | — |
|
HYDROCORTISONE ACETATE
CORTIFOAM |
NDA | — |
|
ALPROSTADIL
MUSE |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.